Dashboard
Manage Tickers

ADNTAdient plc

NYSE adient.com


$ 30.72 $ -0.30 (-0.97 %)    

Monday, 29-Apr-2024 15:34:29 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 431.49 $ -1.66 (-0.38 %)
DIA $ 383.22 $ 0.84 (0.22 %)
SPY $ 508.78 $ -1.48 (-0.29 %)
TLT $ 88.70 $ 0.04 (0.05 %)
GLD $ 216.03 $ -0.59 (-0.27 %)
$ 30.42
$ 31.02
$ 27.73 x 100
$ 30.73 x 100
$ 30.67 - $ 31.13
$ 27.73 - $ 46.51
1,009,356
na
2.85B
$ 2.21
$ 13.37
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 02-07-2024 12-31-2023 10-Q
2 11-17-2023 09-30-2023 10-K
3 08-02-2023 06-30-2023 10-Q
4 05-03-2023 03-31-2023 10-Q
5 02-07-2023 12-31-2022 10-Q
6 11-22-2022 09-30-2022 10-K
7 08-05-2022 06-30-2022 10-Q
8 05-05-2022 03-31-2022 10-Q
9 02-04-2022 12-31-2021 10-Q
10 11-23-2021 09-30-2021 10-K
11 08-05-2021 06-30-2021 10-Q
12 05-06-2021 03-31-2021 10-Q
13 02-05-2021 12-31-2020 10-Q
14 11-30-2020 09-30-2020 10-K
15 08-06-2020 06-30-2020 10-Q
16 05-05-2020 03-31-2020 10-Q
17 02-07-2020 12-31-2019 10-Q
18 11-22-2019 09-30-2019 10-K
19 08-07-2019 06-30-2019 10-Q
20 05-09-2019 03-31-2019 10-Q
21 02-11-2019 12-31-2018 10-Q
22 11-29-2018 09-30-2018 10-K
23 07-30-2018 06-30-2018 10-Q
24 05-07-2018 03-31-2018 10-Q
25 01-30-2018 12-31-2017 10-Q
26 11-22-2017 09-30-2017 10-K
27 07-31-2017 06-30-2017 10-Q
28 05-01-2017 03-31-2017 10-Q
29 02-08-2017 12-31-2016 10-Q
30 11-29-2016 09-30-2016 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

automotive-seating-maker-adient-to-slash-jobs-in-europe
Automotive Seating Maker Adient To Slash J...
04/23/2024 10:48:19

Adient has put forward restructuring plans in Europe to reduce operating, administrative and engineering costs. The plan primar...

jp-morgan-maintains-neutral-on-adient-lowers-price-target-to-37
JP Morgan Maintains Neutral on Adient, Low...
04/22/2024 14:27:18

JP Morgan analyst Ryan Brinkman maintains Adient (NYSE:ADNT) with a Neutral and lowers the price target from $40 to $37.

on-april-22-2024-adient-reveals-restructuring-plans-in-europe-to-reduce-costs-primarily-through-workforce-reductions---filing
On April 22, 2024, Adient Reveals Restruct...
04/22/2024 11:41:45

The plans were initiated by Adient’s management as of March 31, 2024, and the affected employees were notified earlier today. A...

navigating-5-analyst-ratings-for-adient
Navigating 5 Analyst Ratings For Adient
04/10/2024 20:00:22

barclays-downgrades-adient-to-equal-weight-lowers-price-target-to-37
Barclays Downgrades Adient to Equal-Weight...
04/10/2024 14:53:01

Barclays analyst Dan Levy downgrades Adient (NYSE:ADNT) from Overweight to Equal-Weight and lowers the price target from $41...

b-of-a-securities-maintains-buy-on-adient-lowers-price-target-to-46
B of A Securities Maintains Buy on Adient,...
04/10/2024 12:00:20

B of A Securities analyst John Murphy maintains Adient (NYSE:ADNT) with a Buy and lowers the price target from $50 to $46.

jp-morgan-maintains-neutral-on-adient-lowers-price-target-to-40
JP Morgan Maintains Neutral on Adient, Low...
02/28/2024 14:51:38

JP Morgan analyst Ryan Brinkman maintains Adient (NYSE:ADNT) with a Neutral and lowers the price target from $41 to $40.

wells-fargo-maintains-overweight-on-adient-lowers-price-target-to-40
Wells Fargo Maintains Overweight on Adient...
02/08/2024 13:40:42

Wells Fargo analyst Colin Langan maintains Adient (NYSE:ADNT) with a Overweight and lowers the price target from $41 to $40.

adient-reiterates-fy24-sales-outlook-of-154b-155b-vs-1559b-estimate-forecasts-adj-ebitda-of-985m-in-fy24
Adient Reiterates FY24 Sales Outlook Of $1...
02/07/2024 11:58:57

adient-q1-adj-eps-031-misses-047-estimate-sales-3660b-miss-3707b-estimate
Adient Q1 Adj. EPS $0.31 Misses $0.47 Esti...
02/07/2024 11:56:27

earnings-scheduled-for-february-7-2024
Earnings Scheduled For February 7, 2024
02/07/2024 10:13:28

Companies Reporting Before The Bell • Madison Square Garden (NYSE:MSGE) is expected to report quarterly loss at $0.80 per shar...

earnings-outlook-for-adient
Earnings Outlook For Adient
02/06/2024 15:01:39

barclays-maintains-overweight-on-adient-lowers-price-target-to-43
Barclays Maintains Overweight on Adient, L...
01/24/2024 20:36:51

Barclays analyst Dan Levy maintains Adient (NYSE:ADNT) with a Overweight and lowers the price target from $47 to $43.

why-automotive-seating-company-adient-shares-are-gaining-today
Why Automotive Seating Company Adient Shar...
01/22/2024 14:59:17

Adient's latest financial numbers provided showcase a remarkable resilience in the face of industry-wide challenges, with a...

adient-sees-preliminary-q1-2024-revenue-37b-vs-372b-est
Adient Sees Preliminary Q1 2024 Revenue ~$...
01/22/2024 13:22:52

where-adient-stands-with-analysts
Where Adient Stands With Analysts
11/14/2023 17:00:12

morgan-stanley-maintains-underweight-on-adient-lowers-price-target-to-35
Morgan Stanley Maintains Underweight on Ad...
11/14/2023 13:59:38

Morgan Stanley analyst Adam Jonas maintains Adient (NYSE:ADNT) with a Underweight and lowers the price target from $38 to $35.

wells-fargo-maintains-overweight-on-adient-lowers-price-target-to-41
Wells Fargo Maintains Overweight on Adient...
11/09/2023 15:39:46

Wells Fargo analyst Colin Langan maintains Adient (NYSE:ADNT) with a Overweight and lowers the price target from $49 to $41.

why-toast-shares-are-trading-lower-by-around-17-here-are-other-stocks-moving-in-wednesdays-mid-day-session
Why Toast Shares Are Trading Lower By Arou...
11/08/2023 18:41:58

Gainers Heart Test Laboratories, Inc. (NASDAQ: HSCS) shares climbed 96% to $0.2921 after falling over 7% on Tuesday.

adient-sees-fy24-revenue-of-156b---157b-vs-1543b-est
Adient Sees FY24 Revenue Of $15.6B - $15.7...
11/08/2023 11:56:31

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION